| GUARDANT HEALTH CL. A |
| USA |
| Gesundheit |
| US40131M1099 / A2N5RY |
| 5GH (Frankfurt) / GH (NASDAQ) |
| FRA:5GH, ETR:5GH, 5GH:GR, NASDAQ:GH |
| - |
| https://www.guardanthealt.. |
|
Guardant Health Inc. is a precision oncology company that develops and provides blood and tissue-based tests, along with vast data sets and advanced analytics, to support cancer treatment, monitoring, and early detection. Its core offerings include t..
>Volltext.. |
| 9752.3 Mio. EUR |
| 10184.41 Mio. EUR |
| 837.58 Mio. EUR |
| -338.63 Mio. EUR |
| -355.05 Mio. EUR |
| -2.83 EUR |
| 1458.6 Mio. EUR |
| 322.57 Mio. EUR |
| -157.58 Mio. EUR |
| 3.97 |
| 17.12% |
| 15.92% |
| - |
| - |
| - |
| GUARDANT HEALTH |
| 12.04.26 |